Question 1

What are the potential side effects of Xeloda compared to 5-Fluorouracil and Leucovorin?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer clinical trial (NCT00009737). Contact the study team or your healthcare provider for specific answers.

Question 2

How long will I need to participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer clinical trial (NCT00009737). Contact the study team or your healthcare provider for specific answers.

Question 3

What kind of monitoring will I receive during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer clinical trial (NCT00009737). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any other treatment options I should consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer clinical trial (NCT00009737). Contact the study team or your healthcare provider for specific answers.

Question 5

How will this trial affect my recovery from surgery?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer clinical trial (NCT00009737). Contact the study team or your healthcare provider for specific answers.

What this study is about